FDA 510(k) Clearance of NOW® Influenza A & B Rapid Test

Binax, Inc., a leading developer of rapid diagnostic tests, have announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the NOW® Influenza A & B test. This latest test from Binax replaces two individual tests, NOW Flu A and NOW Flu B, and complements the company’s portfolio of diagnostic tests for respiratory tract infections.

NOW Influenza A & B is an easy, one-step test that is as simple to read as a pregnancy test with results available in 15 minutes. Performance is comparable to NOW Flu A and NOW Flu B tests currently on the market. The advantage of the new test is the ability to identify both flu A and flu B and differentiate between the two using one simple device.


NOTE: This item is from our 'historic' database and may contain information which is not up to date.

Source : Binax, Inc. [USA]
Now part of Alere, Inc View Company Information

Posted on November 1, 2004